Where do Inhibrx Biosciences, Inc.'s ratios come from?

Every ratio is computed from Inhibrx Biosciences, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

	FY'25	FY'24	FY'23
Profitability
Operating margin	-10,386.5%+155,337pp	-165,724%-153,545pp	-12,178.9%—
Net margin	-10,773.5%-878,492pp	867,718.5%+881,127pp	-13,408.9%—
Returns
Return on equity	-197.8%-2,158pp	1,960%+2,435pp	-475.3%—
Efficiency
Asset turnover	0×0.0×	0×—	——
Liquidity
Current ratio	3.9×0.0×	3.9×-1.3×	5.2×—
Leverage
Debt-to-equity	13.4×+13.3×	0.1×-4.8×	4.8×—
Per Share
Book value per share	$0.52-94.2%	$8.92+141%	$3.69—
Valuation
Market capitalization	$1.4B+546%	$222.93M-59.5%	$550.08M+54.2%
Price / sales	1,073.7×—	1,114.6×+809×	305.6×—
Price / book	143.7×+142×	1.7×-11.0×	12.6×+6.5×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Inhibrx Biosciences, Inc..

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

Where do Inhibrx Biosciences, Inc.'s ratios come from?: Every ratio is computed from Inhibrx Biosciences, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.